A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint
SOMAÍ Pharmaceuticals has raised $10.0M in total funding. The most recent round was Series B. The last funding was announced in July 2024.
SOMAÍ Pharmaceuticals's investors include Portugal 2020.
SOMAÍ Pharmaceuticals is headquartered in Dublin, Ireland.
A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint
SOMAÍ Pharmaceuticals is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SOMA√ç Pharmaceuticals — Funding & Investors." VCBacked, July 15, 2024, https://www.vcbacked.co/company/soma-pharmaceuticals. Accessed July 19, 2026.
VCBacked. (2024). SOMA√ç Pharmaceuticals — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/soma-pharmaceuticals
{{cite web |title=SOMA√ç Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/soma-pharmaceuticals |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated